Ccm Investment Advisers LLC Gilead Sciences, Inc. Transaction History

Ccm Investment Advisers LLC

$887 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$63.15 - $72.88 $76,095 - $87,820	-1,205 Reduced 9.93%	10,925 $749,000
Q1 2024 May 17, 2024	SELL	$71.58 - $87.29 $9.33 Million - $11.4 Million	-130,405 Reduced 91.49%	12,130 $888,000
Q4 2023 Mar 05, 2024	SELL	$73.27 - $83.09 $902,466 - $1.02 Million	-12,317 Reduced 7.95%	142,535 $11.5 Million
Q3 2023 Dec 08, 2023	BUY	$73.94 - $80.67 $462,716 - $504,832	6,258 Added 4.21%	154,852 $11.6 Million
Q2 2023 Aug 21, 2023	BUY	$76.01 - $86.7 $428,164 - $488,381	5,633 Added 3.94%	148,594 $11.5 Million
Q1 2023 May 17, 2023	BUY	$77.31 - $88.08 $2.81 Million - $3.2 Million	36,326 Added 34.07%	142,961 $11.9 Million
Q4 2022 Feb 15, 2023	SELL	$62.32 - $89.47 $704,465 - $1.01 Million	-11,304 Reduced 9.58%	106,635 $9.15 Million
Q3 2022 Nov 09, 2022	BUY	$59.54 - $68.01 $810,339 - $925,616	13,610 Added 13.05%	117,939 $7.28 Million
Q2 2022 Jul 27, 2022	SELL	$57.72 - $65.01 $303,030 - $341,302	-5,250 Reduced 4.79%	104,329 $6.45 Million
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $2.67 Million - $3.35 Million	-46,149 Reduced 29.63%	109,579 $6.51 Million
Q4 2021 Feb 01, 2022	BUY	$64.88 - $73.64 $93,037 - $105,599	1,434 Added 0.93%	155,728 $11.3 Million
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $363,630 - $392,317	5,372 Added 3.61%	154,294 $10.8 Million
Q2 2021 Jul 30, 2021	BUY	$63.47 - $69.35 $417,315 - $455,976	6,575 Added 4.62%	148,922 $10.3 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $564,000 - $643,523	9,400 Added 7.07%	142,347 $9.2 Million
Q4 2020 Feb 25, 2021	SELL	$56.65 - $64.55 $156,807 - $178,674	-2,768 Reduced 2.04%	132,947 $7.75 Million
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $168,353 - $211,674	-2,711 Reduced 1.96%	135,715 $8.58 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $260,713 - $302,736	3,604 Added 2.67%	138,426 $10.7 Million
Q1 2020 May 22, 2020	SELL	$62.63 - $80.22 $104,967 - $134,448	-1,676 Reduced 1.23%	134,822 $10.1 Million
Q4 2019 Feb 20, 2020	BUY	$61.62 - $67.78 $194,472 - $213,913	3,156 Added 2.37%	136,498 $8.87 Million
Q3 2019 Nov 19, 2019	BUY	$62.51 - $69.0 $8.34 Million - $9.2 Million	133,342 New	133,342 $8.45 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.

Account